| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
* Institute of Biochemistry,
World Health Organization-Immunology Research and Training Center, Institute of Biochemistry, and
Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne, Epalinges, Switzerland;
Institut für Medizinische Mikrobiologie, Marburg, Germany;
¶ Dipartimento di Medicina Interna, Sezione di Immunoallergologia e Malattie dell’Apparato Respiratorio, Universita’ degli Studi di Firenze, Firenze, Italy;
|| Max-Planck-Institut für Immunbiologie, Hans-Spemann Laboratories, Freiburg, Germany; and
# Department of Genetics and Microbiology, University of Geneva Medical School, Geneva, Switzerland
The MHC class II (MHC-II) transactivator (CIITA) is the master transcriptional regulator of genes involved in MHC-II-restricted Ag presentation. Fine tuning of CIITA gene expression determines the cell type-specific expression of MHC-II genes. This regulation is achieved by the selective usage of multiple CIITA promoters. It has recently been suggested that CIITA also contributes to Th cell differentiation by suppressing IL-4 expression in Th1 cells. In this study, we show that endogenous CIITA is expressed at low levels in activated mouse T cells. Importantly CIITA is not regulated differentially in murine and human Th1 and Th2 cells. Ectopic expression of a CIITA transgene in multiple mouse cell types including T cells, does not interfere with normal development of CD4+ T cells. However, upon TCR activation the CIITA transgenic CD4+ T cells preferentially differentiate into IL-4-secreting Th2-type cells. These results imply that CIITA is not a direct Th1-specific repressor of the IL-4 gene and that tight control over the expression of CIITA and MHC-II is required to maintain the normal balance between Th1 and Th2 responses.
This article has been cited by other articles:
|
|
 |
|
  M. P. Mycko, I. Ferrero, A. Wilson, W. Jiang, T. Bianchi, A. Trumpp, and H. R. MacDonald Selective Requirement for c-Myc at an Early Stage of V{alpha}14i NKT Cell Development J. Immunol., April 15, 2009; 182(8): 4641 - 4648. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Chevrier, C. Genton, A. Kallies, A. Karnowski, L. A. Otten, B. Malissen, M. Malissen, M. Botto, L. M. Corcoran, S. L. Nutt, et al. CD93 is required for maintenance of antibody secretion and persistence of plasma cells in the bone marrow niche PNAS, March 10, 2009; 106(10): 3895 - 3900. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q.-G. Steiner, L. A. Otten, M. J. Hicks, G. Kaya, F. Grosjean, E. Saeuberli, C. Lavanchy, F. Beermann, K. L. McClain, and H. Acha-Orbea In vivo transformation of mouse conventional CD8{alpha}+ dendritic cells leads to progressive multisystem histiocytosis Blood, February 15, 2008; 111(4): 2073 - 2082. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Charmoy, R. Megnekou, C. Allenbach, C. Zweifel, C. Perez, K. Monnat, M. Breton, C. Ronet, P. Launois, and F. Tacchini-Cottier Leishmania major induces distinct neutrophil phenotypes in mice that are resistant or susceptible to infection J. Leukoc. Biol., August 1, 2007; 82(2): 288 - 299. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. R. Patel, M. H. Kaplan, and C.-H. Chang Altered Th1 Cell Differentiation Programming by CIITA Deficiency J. Immunol., November 1, 2004; 173(9): 5501 - 5508. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. S. Park, Y. Bae, D. H. Chung, Y.-L. Choi, B. K. Kim, Y. C. Sung, E. Y. Choi, S. H. Park, and K. C. Jung T cell expression of CIITA represses Th1 immunity Int. Immunol., October 1, 2004; 16(10): 1355 - 1364. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. R. Godfrey, M. R. Krampf, P. A. Taylor, and B. R. Blazar Ex vivo depletion of alloreactive cells based on CFSE dye dilution, activation antigen selection, and dendritic cell stimulation Blood, February 1, 2004; 103(3): 1158 - 1165. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-H. Chang, T. Gourley, D. Patel, L. A. Otten, W. Reith, and H. Acha-Orbea CIITA Expression and Th1-Th2 Balance J. Immunol., May 1, 2003; 170(9): 4425 - 4425. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
